
BPC-157 (Injectable) in South Carolina
Doctor-prescribed BPC-157 (Injectable) for South Carolina residents. Reviewed by licensed South Carolina physicians, compounded at FDA-registered pharmacies, and shipped to your door.
The pepti Pen cartridge for this treatment is sold out right now. The vial is the same medication at our best price.
All-in monthly price
No membership fee · this is the full price · free shipping · avg 4-week supply
Add in-depth bloodwork
Optional — add a physician-reviewed at-home blood panel to your plan.
Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.
This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.

Reviewed by Dr. Gene, MD · Board-certified Family Medicine
Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.
How it works in South Carolina
- 1Complete a free online intake (~5 minutes).
- 2A licensed South Carolina physician reviews your case within 24 hours.
- 3Your prescription ships from our FDA-registered compounding pharmacy.
- 4Free shipping arrives 2–4 business days later. Refills ship automatically when your supply runs out — cancel anytime.
What BPC-157 (Injectable) does
Body Protection Compound-157 supports tissue healing, gut repair, and recovery from injuries.
Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.
Quality
Every batch independently tested
Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.
Sterility
USP <71>Confirms the finished preparation is free of viable microorganisms.
Bacterial endotoxins
USP <85>Screens for endotoxins that can cause fever or inflammatory reactions.
Potency
AssayVerifies the labeled concentration of the active peptide is what is in the vial.
Purity
HPLCChecks the active peptide against impurities and degradation products.
Identity
Mass spectrometryConfirms the peptide in the vial is the correct molecule.
pH
USP <791>Confirms the solution sits within the range specified for injection.
Particulate matter
USP <788>Checks the finished vial for visible and sub-visible particles.
Container closure integrity
USP <1207>Confirms the vial seal holds so sterility is maintained through the beyond-use date.
Recent lots
- Lot 100526-BPC-2
Tested 2026-10-07 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
99.1%
- Lot 100526-BPC-3
Tested 2026-10-07 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
99.8%
- Lot 092826-BPC-2
Tested 2026-09-30 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
99.7%
Telemedicine in South Carolina.
South Carolina permits telemedicine prescribing under the South Carolina Telemedicine Act and Board of Medical Examiners rules. A South Carolina-licensed physician can establish the patient relationship through online intake review. Pepti is available in all 50 states and Washington, D.C.
South Carolina cities Pepti serves
+ 11 more cities
, Spartanburg, Hilton Head Island, Bluffton, Fort Mill, Aiken, Anderson, Mauldin, Conway, Simpsonville, Easley, North AugustaYour protocol
How BPC-157 is prescribed in South Carolina.
Who it's for
- Adults recovering from tendon, ligament, muscle, or joint injuries
- Patients with gut discomfort or inflammation their physician wants to support
- People whose training or work keeps re-aggravating the same area
Your physician decides whether BPC-157 is appropriate for you after reviewing your intake and labs.
Directions & duration
Inject 0.18 mL (18 units) subcutaneously once daily as directed.
What's included
- Licensed physician review of your intake, history, and labs
- Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
- Every batch independently tested before release
- Sterile syringes and alcohol prep pads for injectables
- Tracked delivery to your door, refills on schedule
- Message your physician anytime; dose changes without an appointment
Storage & handling
- Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
- One vial is your monthly supply. A fresh vial ships to your South Carolina address every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
- Protect from light. Wipe the stopper with an alcohol pad before every draw.
- Dispose of syringes in the sharps container per the included instructions.
What to expect
A typical course of BPC-157 in South Carolina.
The science
How BPC-157 works, and what the research shows.
How it works
BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protective protein in human gastric juice.
It promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptors at injury sites, and accelerates the healing of tendons, ligaments, muscle, and the GI tract lining.
Clinical evidence
Decades of preclinical research support BPC-157's role in tissue regeneration.
Animal studies have demonstrated accelerated tendon-to-bone healing, Achilles tendon repair, and gut barrier protection in colitis and IBD models.
Chang et al., J Appl Physiol 2011Krivic et al., J Orthop Res 2006Sikiric et al., Curr Pharm Des 2011The mechanism appears to involve upregulation of VEGF and FAK-paxillin signaling at injury sites, driving angiogenesis and fibroblast migration.
Human clinical trials are limited, and BPC-157 remains an investigational compound prescribed off-label by US-licensed physicians under 503A compounding pathways.
References
- Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts · Molecules (2014) · PMID 25415472
- Krivic A, Anic T, Seiwerth S, et al.. Achilles detachment of rat and stable gastric pentadecapeptide BPC 157 · Journal of Orthopaedic Research (2006) · PMID 16583442
- Sikiric P, Seiwerth S, Rucman R, et al.. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract · Current Pharmaceutical Design (2011) · PMID 21548867
- Cerovecki T, Bojanic I, Brcic L, Radic B, et al.. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat · J Orthop Res (2010) · PMID 20225319
- Sikiric P, Seiwerth S, Rucman R, Turkovic B, et al.. Stable gastric pentadecapeptide BPC 157-NO-system relation · Curr Pharm Des (2014) · PMID 23755725
- Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H · Drug Test Anal (2017) · PMID 28035768
- Thomas A, Görgens C, Guddat S et al.. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry · J Sep Sci (2016) · PMID 26578461
- Farrar JT, Young JP Jr, LaMoreaux L, Werth JL et al.. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale · Pain (2001) · PMID 11690728
- Meyer JD, Ho B, Manning MC. Effects of conformation on the chemical stability of pharmaceutically relevant polypeptides · Pharm Biotechnol (2002) · PMID 11987755
- Xu C, Sun L, Ren F, Huang P, et al.. Preclinical Safety Evaluation of Body Protective Compound-157, a Potential Drug for Treating Various Wounds · Regul Toxicol Pharmacol (2020) · PMID 32334036
- He L, Feng D, Guo H, et al.. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs · Front Pharmacol (2022) · PMID 36588717
- Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain · Altern Ther Health Med (2021) · PMID 34324435
- Lee E, Walker C, Ayadi B. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study · Altern Ther Health Med (2024) · PMID 39325560
- Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study · Altern Ther Health Med (2025) · PMID 40131143
- Sikiric P, Seiwerth S, Rucman R et al.. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157 · Curr Pharm Des (2013) · PMID 22950504
- Klicek R, Kolenc D, Suran J et al.. Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability · J Physiol Pharmacol (2013) · PMID 24304574
- Grgic T, Grgic D, Drmic D et al.. Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula · Eur J Pharmacol (2016) · PMID 26875638
- Sikiric P, Drmic D, Sever M et al.. Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy · Curr Pharm Des (2020) · PMID 32329684
- Lojo N, Rasic Z, Zenko Sever A et al.. Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats · PLoS One (2016) · PMID 27627764
- Park JM, Lee HJ, Sikiric P et al.. BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection · Curr Pharm Des (2020) · PMID 32445447
- Bajramagic S, Sever M, Rasic F et al.. Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review · Pharmaceuticals (Basel) (2024) · PMID 39204186
- Józwiak M, Bauer M, Kamysz W et al.. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review · Pharmaceuticals (Basel) (2025) · PMID 40005999
- Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans · Gut (2019) · PMID 31076401
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing · Cell Tissue Res (2019) · PMID 30915550
- Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance · Sports Med (2026) · PMID 41966639
- Djakovic Z, Djakovic I, Cesarec V et al.. Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME · World J Gastroenterol (2016) · PMID 27895400
- Hrelec M, Klicek R, Brcic L et al.. Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy · J Physiol Pharmacol (2009) · PMID 20388960
- Japjec M, Horvat Pavlov K, Petrovic A et al.. Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats · Biomedicines (2021) · PMID 34829776
- Matek D, Matek I, Japjec M et al.. Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review · Pharmaceuticals (Basel) (2026) · PMID 41754849
- Mayfield CK, Bolia IK, Feingold CL et al.. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians · Am J Sports Med (2026) · PMID 41476424
- Biçer O, Adanir O, Güleryüz Y et al.. Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study · Jt Dis Relat Surg (2026) · PMID 42542926
- Mikus D, Sikiric P, Seiwerth S et al.. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice · Burns (2001) · PMID 11718984
- Weber C, Krug O, Kamber M, Thevis M. Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border · Subst Use Misuse (2017) · PMID 28156209
- Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review · HSS J (2025) · PMID 40756949
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
PCAB-accredited pharmacies on every order.
Every fulfillment runs through a PCAB-accredited pharmacy.
See the lab results
- Rigorous third-party quality & safety inspections
- Cleanliness and sterile processes
- Proper ingredient sourcing
- Accurate dosing and formulation
- Staff training and procedures
- Accredited by NABP & ACHC
Frequently asked
about BPC-157 (Injectable) in South Carolina.
Yes. BPC-157 (Injectable) is legal when prescribed by a physician licensed in South Carolina and dispensed by an FDA-registered compounding pharmacy. South Carolina permits telemedicine prescribing under the South Carolina Telemedicine Act and Board of Medical Examiners rules. A South Carolina-licensed physician can establish the patient relationship through online intake review.
Most orders ship from our FDA-registered compounding pharmacy within 1–3 business days after physician approval. Delivery within South Carolina typically arrives 1-3 business days after shipment. Pepti serves patients across South Carolina including Charleston, Columbia, North Charleston, and Mount Pleasant.
No. Pepti operates as a fully telehealth platform in South Carolina. South Carolina permits telemedicine prescribing under the South Carolina Telemedicine Act and Board of Medical Examiners rules. A South Carolina-licensed physician can establish the patient relationship through online intake review.
BPC-157 (Injectable) starts at $209 at Pepti. Pepti is subscription-based — your refill ships when your supply runs out, and you can cancel anytime. Pricing is the same nationwide — no South Carolina-specific markup. Shipping is free.
Yes — Pepti is available in all 50 states and Washington, D.C. Wherever you are in the country, a physician licensed in your state reviews your intake and your medication ships from an FDA-registered compounding pharmacy.
You don't need an in-person peptide clinic — Pepti provides doctor-prescribed BPC-157 (Injectable) entirely online anywhere in South Carolina. A physician licensed in South Carolina reviews your intake, and your medication ships from an FDA-registered compounding pharmacy to your door. Unlike "research use only" peptide sites, every Pepti order requires a valid patient-specific prescription and a licensed dispensing pharmacy.
No. "Research use only" BPC-157 (Injectable) is sold with no prescription, no physician, and no dispensing pharmacy, and is not legally sold for human use — independent testing of research-grade peptides has repeatedly found underdosing, mislabeling, and contamination. Prescription BPC-157 (Injectable) is compounded for you at an FDA-registered US pharmacy after a licensed physician's review. When comparing BPC-157 (Injectable) options in South Carolina, only consider providers that can name their prescribing physicians and their dispensing pharmacy.
33 more questions about Pepti, answered.Show fewer
Pepti serves all of South Carolina. A physician licensed in South Carolina reviews every order within 4 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any South Carolina street address. The price is the same as every other state.
Yes. The whole process is online in South Carolina: a free assessment, physician review, messaging, dose changes, and refills through your Pepti account or the Hello Pepti app. No clinic visit is required.
Pepti ships BPC-157 to South Carolina directly from the pharmacy: free, tracked, unbranded, in insulated packaging with ice packs for refrigerated medication. The pharmacy compounds in 1-3 business days and delivery takes 1-3 business days after shipment. PO Boxes are not accepted.
Every treatment on Pepti's catalog ships to South Carolina. Eligibility is confirmed during the assessment from your South Carolina shipping address, and if anything ever cannot ship to your address it is refunded.
The same as everywhere Pepti serves: one all-in monthly price per treatment that includes the medication, the physician, and shipping, with no South Carolina-specific markup and no membership or consult fee. Every price is on the product page.
Yes. Pepti's physicians hold licenses in South Carolina, and only a physician licensed where you live reviews and prescribes your order. Their names and credentials are on the providers page.
Yes. Pepti's partner pharmacies are state-licensed, FDA-registered 503A compounding pharmacies licensed to dispense into South Carolina, and every batch is independently tested before it ships.
Body Protection Compound-157 supports tissue healing, gut repair, and recovery from injuries. BPC-157 is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.
BPC-157 is commonly prescribed for: Adults recovering from tendon, ligament, muscle, or joint injuries; Patients with gut discomfort or inflammation their physician wants to support; People whose training or work keeps re-aggravating the same area. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.
Yes. BPC-157 is prescription-only. The free online assessment takes about five minutes, a physician licensed in South Carolina reviews it within 4 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.
No. BPC-157 can be prescribed from the assessment alone. Bloodwork is required only for the GLP-1s and growth-hormone secretagogues, and the intake tells you if a medication on your order needs it.
BPC-157 is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account. It is also available as a pre-filled pepti Pen for $319.
One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.
Once per fill, $209 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.
The compounded BPC-157 with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.
Reported side effects of BPC-157 are usually mild: mild redness or swelling at injection site; temporary fatigue or headache; mild nausea (uncommon); slight dizziness on first dose (rare). The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.
Response varies by person, goal, and dose, and BPC-157 is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.
Yes. Request it from your account or the app; your physician approves or declines. If approved you pay for the additional medication at the pharmacy's cost and the new dose applies to your next shipment.
Yes. Add BPC-157 to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.
No. Compounded BPC-157 is not FDA-approved. It is prepared to your physician's prescription by a state-licensed, FDA-registered 503A pharmacy and every batch is independently tested before release.
Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in South Carolina. Research-use-only BPC-157 sold without a prescription is labeled not for human use and is a different product.
BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protective protein in human gastric juice. At Pepti it is prescribed to support injury recovery, gut healing, reduced inflammation, joint support. Individual response varies, and your physician sets expectations at approval.
BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protective protein in human gastric juice. It promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptors at injury sites, and accelerates the healing of tendons, ligaments, muscle, and the GI tract lining. Compounded BPC-157 is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.
BPC-157 is prescribed for injury recovery, gut healing, reduced inflammation, joint support. It is commonly requested by adults recovering from tendon, ligament, muscle, or joint injuries; patients with gut discomfort or inflammation their physician wants to support; people whose training or work keeps re-aggravating the same area. Whether it is appropriate for you is the reviewing physician's decision.
BPC-157 is studied for injury recovery, gut healing, reduced inflammation, joint support. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.
Decades of preclinical research support BPC-157's role in tissue regeneration. Animal studies have demonstrated accelerated tendon-to-bone healing (Chang et al., J Appl Physiol 2011), Achilles tendon repair (Krivic et al., J Orthop Res 2006), and gut barrier protection in colitis and IBD models (Sikiric et al., Curr Pharm Des 2011). The mechanism appears to involve upregulation of VEGF and FAK-paxillin signaling at injury sites, driving angiogenesis and fibroblast migration. Human clinical trials are limited, and BPC-157 remains an investigational compound prescribed off-label by US-licensed physicians under 503A compounding pathways. References are listed on this page.
BPC-157 is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients. The physician screens for these in your intake, and anything that rules BPC-157 out means it is not prescribed and is refunded.
At Pepti. Complete the free assessment, a physician licensed in South Carolina reviews it within 4 hours, and if appropriate BPC-157 is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $209 per month, all-in. Not prescribed means refunded.
Injectable vial: 10 mL at 3 mg/mL, containing 30 mg BPC-157. Injectable vial: 5 mL at 3 mg/mL, containing 15 mg BPC-157. Injectable vial: 5 mL at 2 mg/mL, containing 10 mg BPC-157. Injectable vial: 5 mL at 1 mg/mL, containing 5 mg BPC-157. Pepti Pen cartridge: 3 mL cartridge (300 units) at 3 mg/mL, containing 9 mg BPC-157. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.
Yes. BPC-157 is available as a pre-filled pepti Pen cartridge for $319 per month, versus $209 as a vial. Same medication, same pharmacy; the reusable injector is free with your first pen order. Choose the format in the cart or ask your physician.
$209 per month covers the compounded BPC-157, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.
Yes. BPC-157 is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.
BPC-157 ships to 50 states, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.
BPC-157 (Injectable) in every state
Pepti is available in all 50 states and Washington, D.C.
Pepti operates in South Carolina through licensed physician partnerships. Compounded medications are produced at FDA-registered 503A pharmacies. Treatment decisions are made by your prescribing physician.